Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07384156 · ClinicalTrials.gov registry record · Phase 1
Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners
A Phase 1 study, sponsored by Penn State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT07384156 is a Phase 1 study that has not yet begun recruiting, run by Penn State University. The registered enrollment target is 60 participants.
The verdict
NCT07384156, a Phase 1 study, has not yet begun recruiting, sponsored by Penn State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine whether adding Integrated Decoding and Encoding instruction to the ALLSTAR literacy program improves reading outcomes for students with significant literacy and communication needs. The study will also examine how students' reading skills change over time across instructional conditions. The main questions it aims to answer are: Do students who receive ALLSTAR with Integrated Decoding and Encoding instruction demonstrate greater improvements in literacy outcomes than students who receive ALLSTAR as standard care alone? How do students' literacy skills change from baseline to mid-intervention and post-intervention across the two instructional conditions? Researchers will compare two groups using a randomized controlled trial design. One group will receive 60 lessons of ALLSTAR as the standard of care (ALLSTAR-SC), and the other group will receive 60 lessons of ALLSTAR with the addition of Integrated Decoding and Encoding lessons (ALLSTAR-I\*). Literacy outcomes will be measured using repeated assessment probes at baseline (0 Lessons), after 30-40 lessons, and after 60 lessons to evaluate differences between groups and changes over time in the individuals.
Interventions
- BEHAVIORAL ALLSTAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2031-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07384156
The ClinicalTrials.gov registry entry for NCT07384156 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALLSTAR is the first listed.
NCT07384156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07384156 about?
NCT07384156 is a clinical study titled "Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners". The goal of this clinical trial is to determine whether adding Integrated Decoding and Encoding instruction to the ALLSTAR literacy program improves reading outcomes for students with significant literacy and communication needs. The study will also examine how students' reading skills change over t...
What is the current status of trial NCT07384156?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2026-03-01. Estimated completion is 2031-02-28.
What interventions are being tested in trial NCT07384156?
The interventions under investigation include: ALLSTAR (BEHAVIORAL).
Who is sponsoring clinical trial NCT07384156?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.